Stay updated on Sotatercept in PAH High-Risk Mortality Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.

Latest updates to the Sotatercept in PAH High-Risk Mortality Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference2%
- Check15 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the previous version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedVersion bumped to v3.0.2 (from v3.0.1); the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check43 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of topics related to drug safety and high blood pressure prevention. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%
- Check51 days agoChange DetectedThe webpage has been updated to include new study results and publications related to the effects of sotatercept on pulmonary arterial hypertension, with specific details on participant eligibility, treatment protocols, and outcome measures. Notably, the results posting date has been updated to August 22, 2025.SummaryDifference46%
Stay in the know with updates to Sotatercept in PAH High-Risk Mortality Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.